Eplerenone in Metabolic Syndrome: An investigation into the effects of Eplerenone on perivascular adipose tissue and small artery tone in obesity.
Phase of Trial: Phase II
Latest Information Update: 08 Dec 2012
At a glance
- Drugs Eplerenone (Primary)
- Indications Hypertension; Obesity
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 08 Nov 2012 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
- 25 Jun 2011 New trial record